THE DUBERSTEIN GROUP INC.

Lobbying for PHRMA INC. · Represents leading research-based pharmaceutical and biotechnology companies in the US

Filing 1st Quarter - Termination

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$25,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Representation ended

Jan 31, 2025

The registrant reported terminating its work for this client.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

PBM issues Issues related to the 340B program

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.